AzTrials
AzTrials

FootwearNCT04971915

The Effect of Minimalist Footwear on the Anthropometric and Biomechanical Parameters of the Lower Limb and Foot

A study testing minimalist footwear in people with Footwear, run by Palacky University at 2 sites in Czechia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to determine whether 6months of wearing minimalist footwear causes changes in anthropometric parameters of the foot and the biomechanical parameters of the foot and lower limb. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Footwear
What is being tested?
minimalist footwear
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
2 sitesCzechia
Study dates
5 Jul 2021to 5 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy individuals
  • Individuals without previous experience in wearing minimalist footwear

Who cannot join

  • Significant deformities of the feet and toes
  • Pain of the musculoskeletal system
  • Injury, congenital or gained defect of the musculoskeletal or neural system in past
  • Undergo operation of lower limbs in past or during research

Trial locations and contacts

2 sites in 1 country.

Czechia2 sites
  • Faculty of Physical Culture, Palacky University Olomouc

    Olomouc, 77111

  • Palacky University Olomouc, Faculty of Physical Culture

    Olomouc, 77900

Other trials in Czechia

About this study

Official title: The Effect of Minimalist Footwear on the Anthropometric and Biomechanical Parameters of the Lower Limb and Foot During Long-Term Wearing: A Randomized Clinical Trial

The study aims to determine whether 6months of wearing minimalist footwear causes changes in anthropometric parameters of the foot and the biomechanical parameters of the foot and lower limb.

Read the detailed description

The minimalist footwear represents an alternative style of footwear wearing, which could allow the foot to move more naturally compared to the footwear wearing in conventional footwear. That footwear is characterized by no cushioning, wide toe box, zero foot drop, thin sole (1,5 - 8 mm), low weight, and high flexibility of footwear. This study aims to determine the effect of 6months of wearing minimalist footwear on the foot and lower limb's anthropometric and biomechanical parameters.

The study is designed as a parallel interventional study. The sample size consists of 50 healthy individuals divided into experimental and control groups by randomization. All participants undergo the initial examination and baseline and final measurement focused on the foot anthropometry and kinetics and kinematics of the foot and lower limb during walking. Besides, the experimental group undergoes a 6months intervention of wearing minimalist footwear, during which the participants will record their movement behavior by electronic diary.

Conditions
Footwear
Being tested
minimalist footwear
Keywords
minimalist footwear, shoes, biomechanics, anthropometric parameters, foot, walking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • minimalist footwearOther

    The intervention consists of wearing the minimalist footwear in recommended progression during the interventional period (6months). The intial load starts at 2,500 steps a day and will be gradually increased up according to the participant´s tolerance rate to the footwear wearing to fully use over the final period. Participants are instructed to report all issues and difficulties possibly connected to the intervention. There will be the opportunity to consult any issue connected with footwear or their wearing through the duration of the research.

Study groups in NCT04971915
Study groupRoleWhat they receive
minimalist footwearExperimentalThe participants in the experimental group will receive one pair of minimalist footwear and will be asked to use them for the interventional period.
Receives: Other: minimalist footwear
controlNo interventionThe participants in the control group will be asked to wear their standard footwear as before participating in the study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle

    Range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  2. Change in maximal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle

    Maximal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  3. Change in minimal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle

    Minimal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  4. Change in angular velocity of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle

    Angular velocity of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  5. Change in walking velocity

    Walking velocity will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  6. Change in walking cadence

    Walking cadence will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  7. Change in step length during walking

    Step length will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  8. Change in duration of stance phase of the gait cycle

    Duration of stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  9. Change in maximum value of the vertical component of ground reaction force during walking

    Maximum value of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  10. Change in minimum value of the vertical component of ground reaction force during walking

    Minimum value of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  11. Change in impulse of the vertical component of ground reaction force during walking

    Impulse of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  12. Change in lower limbs joints moments during walking

    Lower limbs joints moments will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain).

    Measured: at baseline and at the end of 6 months intervention

  13. Change in peak plantar pressure at anatomical regions of the foot sole during walking

    Peak plantar pressure at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).

    Measured: at baseline and at the end of 6 months intervention

  14. Change in contact time at anatomical regions of the foot sole during walking

    Contact time at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).

    Measured: at baseline and at the end of 6 months intervention

  15. Change in contact area at anatomical regions of the foot sole during walking.

    Contact area at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).

    Measured: at baseline and at the end of 6 months intervention

  16. Change in pressure-time integral at anatomical regions of the foot sole during walking

    Pressure-time integral at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).

    Measured: at baseline and at the end of 6 months intervention

  17. Change in maximum force at anatomical regions of the foot sole during walking

    Maximum force at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium).

    Measured: at baseline and at the end of 6 months intervention

  18. Change in foot length

    Foot length will be measured by RSS 3D Scanner (RSScan International NV, Paal, Belgium).

    Measured: at baseline and at the end of 6 months intervention

  19. Change in foot width

    Foot width will be measured by RSS 3D Scanner (RSScan International NV, Paal, Belgium).

    Measured: at baseline and at the end of 6 months intervention

  20. Change in tactile-foot perception

    Tactile-foot perception will be measured by Baseline Tactile Monofilaments (Fabrication Enterprises, White Plains, NY, USA).

    Measured: at baseline and at the end of 6 months intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2021
  2. Study start5 Jul 2021
  3. Primary completion5 Dec 2022
  4. Study completion5 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04971915
Sponsor's protocol ID
IGA_FTK_2021_010
Status last verified
Dec 2022
First submitted
5 Jul 2021
Last updated
16 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing minimalist footwear in people with Footwear, run by Palacky University at 2 sites in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle (time frame: at baseline and at the end of 6 months intervention). The study lists 20 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in